Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors.

CONCLUSIONS: Only few studies have examined the association between NETs and SPMs. Our study showed that the risk of second cancer following NETs is increased. In this single-institution retrospective review, our incidence of additional malignancies in patients with NET was 11.4%. PMID: 31505502 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31505502?dopt=Abstract

Source: Oncology - September 9, 2019 Category: Cancer & Oncology Authors: Verrico M, Rossi L, Tomao S, Colonna M, Vici P, Tomao F Tags: Oncology Source Type: research